Patent details

Basic Information

Publication number:

EP2421562

PCT Application Number:

CA2010000618

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107665655

PCT Publication Number:

WO2010121379

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF OVARIAN CANCER USING AN ANTICANCER AGENT CONJUGATED TO AN ANGIOPEP-2 ANALOG

French Title of Invention:

TRAITEMENT D'UN CANCER DE L'OVAIRE À L'AIDE D'UN AGENT ANTICANCÉREUX CONJUGUÉ À UN ANALOGUE D'ANGIOPEP-2

German Title of Invention:

BEHANDLUNG VON OVARIALKARZINOM MIT EINEM AN EIN ANGIOPEP-2-ANALOGON KONJUGIERTEN ANTITUMORWIRKSTOFF

SPC Number:

Dates

Filing date:

20/04/2010

Grant date:

13/03/2019

EP Publication Date:

29/02/2012

PCT Publication Date:

28/10/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/03/2019

EP B1 Publication Date:

13/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/04/2019

Expiration date:

20/04/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/03/2019

 

 

Name:

Angiochem Inc.

Address:

4150 rue Ste. Catherine Ouest, Suite 490, Westmount, QC H3Z 2Y5, Canada (CA)

Inventor

1

Name:

CASTAIGNE, Jean-Paul

Address:

Canada (CA)

2

Name:

LAWRENCE, Betty

Address:

Canada (CA)

3

Name:

DEMEULE, Michel

Address:

Canada (CA)

Priority

Priority Number:

171040 P

Priority Date:

20/04/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/337; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201911

Publication date:

13/03/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages